Author Archives: Jean-Michel Pawlotsky
Hepatitis C Virus Resistance to Direct-Acting Antiviral Drugs in Interferon-Free Regimens
Treatment of hepatitis C virus (HCV) infection has progressed considerably with the approval of interferon-free, direct-acting antiviral (DAA)-based combination therapies. Although most treated patients achieve virological cure, HCV resistance to DAAs … Continue reading
Posted in News
Comments Off on Hepatitis C Virus Resistance to Direct-Acting Antiviral Drugs in Interferon-Free Regimens